| Characterization of the oral fungal microbiome (mycobiome) in healthy individuals MA Ghannoum, RJ Jurevic, PK Mukherjee, F Cui, M Sikaroodi, A Naqvi, ... PLoS pathogens 6 (1), e1000713, 2010 | 1428 | 2010 |
| Altered profile of human gut microbiome is associated with cirrhosis and its complications JS Bajaj, DM Heuman, PB Hylemon, AJ Sanyal, MB White, P Monteith, ... Journal of hepatology 60 (5), 940-947, 2014 | 1272 | 2014 |
| Colonic microbiome is altered in alcoholism EA Mutlu, PM Gillevet, H Rangwala, M Sikaroodi, A Naqvi, PA Engen, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 302 (9 …, 2012 | 919 | 2012 |
| Modulation of the fecal bile acid profile by gut microbiota in cirrhosis G Kakiyama, WM Pandak, PM Gillevet, PB Hylemon, DM Heuman, ... Journal of hepatology 58 (5), 949-955, 2013 | 897 | 2013 |
| Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease M Raman, I Ahmed, PM Gillevet, CS Probert, NM Ratcliffe, S Smith, ... Clinical gastroenterology and hepatology 11 (7), 868-875. e3, 2013 | 807 | 2013 |
| Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial JS Bajaj, Z Kassam, A Fagan, EA Gavis, E Liu, IJ Cox, R Kheradman, ... Hepatology 66 (6), 1727-1738, 2017 | 717 | 2017 |
| Linkage of gut microbiome with cognition in hepatic encephalopathy JS Bajaj, JM Ridlon, PB Hylemon, LR Thacker, DM Heuman, S Smith, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 302 (1 …, 2012 | 704 | 2012 |
| Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation JS Bajaj, PB Hylemon, JM Ridlon, DM Heuman, K Daita, MB White, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 303 (6 …, 2012 | 668 | 2012 |
| The genetic data environment an expandable GUI for multiple sequence analysis SW Smith, R Overbeek, CR Woese, W Gilbert, PM Gillevet Bioinformatics 10 (6), 671-675, 1994 | 594 | 1994 |
| Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy JS Bajaj, DM Heuman, AJ Sanyal, PB Hylemon, RK Sterling, RT Stravitz, ... PloS one 8 (4), e60042, 2013 | 521 | 2013 |
| Intestinal dysbiosis: a possible mechanism of alcohol‐induced endotoxemia and alcoholic steatohepatitis in rats E Mutlu, A Keshavarzian, P Engen, CB Forsyth, M Sikaroodi, P Gillevet Alcoholism: Clinical and Experimental Research 33 (10), 1836-1846, 2009 | 447 | 2009 |
| Multitag sequencing ecogenomics analysis-US PM Gillevet US Patent 8,603,749, 2013 | 379 | 2013 |
| Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy JS Bajaj, NS Betrapally, PB Hylemon, DM Heuman, K Daita, MB White, ... Hepatology 62 (4), 1260-1271, 2015 | 375 | 2015 |
| Oral Mycobiome Analysis of HIV-Infected Patients: Identification of Pichia as an Antagonist of Opportunistic Fungi PK Mukherjee, J Chandra, M Retuerto, M Sikaroodi, RE Brown, R Jurevic, ... PLoS pathogens 10 (3), e1003996, 2014 | 369 | 2014 |
| A Highly Selective PCR Protocol for Detecting 16S rRNA Genes of the Genus Pseudomonas (Sensu Stricto) in Environmental Samples F Widmer, RJ Seidler, PM Gillevet, LS Watrud, GD Di Giovanni Applied and Environmental Microbiology 64 (7), 2545-2553, 1998 | 360 | 1998 |
| Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo‐controlled trial JS Bajaj, NH Salzman, C Acharya, RK Sterling, MB White, EA Gavis, ... Hepatology 70 (5), 1690-1703, 2019 | 353 | 2019 |
| Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis JS Bajaj, DM Heuman, PB Hylemon, AJ Sanyal, P Puri, RK Sterling, ... Alimentary pharmacology & therapeutics 39 (10), 1113-1125, 2014 | 339 | 2014 |
| Vaginal microbiome: normalcy vs dysbiosis VS Saraf, SA Sheikh, A Ahmad, PM Gillevet, H Bokhari, S Javed Archives of microbiology 203 (7), 3793-3802, 2021 | 278 | 2021 |
| Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus C Llorente, P Jepsen, T Inamine, L Wang, S Bluemel, HJ Wang, ... Nature communications 8 (1), 837, 2017 | 273 | 2017 |
| A randomized clinical trial of fecal microbiota transplant for alcohol use disorder JS Bajaj, EA Gavis, A Fagan, JB Wade, LR Thacker, M Fuchs, S Patel, ... Hepatology 73 (5), 1688-1700, 2021 | 267 | 2021 |
